NCT07338903Completed
Feasibility and Effects of Home-based Physical Activity Intervention in Patients With Breast Cancer in Indonesia
Move to Improve: Investigating the Feasibility of Embedding Physical Activity Into Routine Breast Cancer Care in Indonesia
Source: ClinicalTrials.gov · Last updated 14 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn the impact and implementation of home-based aerobic and resistance training for patients with breast cancer in Indonesia. The main questions it aims to answer are: * Does the home-based aerobic and resistance training improve physical fitness, fatigue, and quality of life of patients with breast cancer? * Are the benefits of aerobic and resistance training mediated by inflammatory level changes? * What are the barriers and facilitators in implementing the home-based aerobic and resistance training? * Is the home-based aerobic and resistance training feasible to be implemented in Indonesia's setting? To answer those questions, participants will: * Conduct home-based aerobic and resistance training with supervision. * Visit the hospital once every 4 weeks for their routine visits. * Undergo physical fitness test before and after 12 weeks using treadmill test, as well as interviews to assess fatigue, quality of life, and intervention acceptability. * Keep a diary to record the aerobic and resistance training at home. * Undergo routine monitoring by phone every week with the research team.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 4 Jan 2026
- Start date
- 3 Jan 2022
- Primary completion date
- 13 Oct 2022
- Lead sponsor
- Gadjah Mada University
- Diseases
- Childhood cancers
- NCT number
- NCT07338903
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 3 Jan 2022 to the primary completion date, 13 Oct 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of cardiac disease, severe musculoskeletal problems, or other contraindications for exercise.
Lab values
- Had an ejection fraction of \<50%
Who the study is looking for
- Patients with stage I-III hormone-receptor positive breast cancer
- Eastern Cooperative Oncology Group (ECOG) score ≤1
- Had completed primary treatment (e.g., surgery, chemotherapy, and radiotherapy), except for hormonal treatment
- Within 5 years of diagnosis
- Able to perform moderate-intensity physical activity as determined by their oncologist and care team
- Able to read and write in Indonesian
- Willing to provide written informed consent.
Age in the registry: 17 years to 70 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dr. Sardjito General Hospital Coordinator of this site? Confirm its status | Sleman | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.